Illustrative AI review — based on a real open-access article (Åsa Anger et al., BMC Psychiatry, 2023; DOI: 10.1186/s12888-023-05053-8; License: CC-BY 4.0). Not a real journal decision.
Sample / illustrative report only — fictional neuro-oncology manuscript for UI demo. Not a real patient case, not a journal decision. Upload your own manuscript to receive a real review.
ANALYSIS REPORTFictional sample05.07.2026
Introducing Braining—physical exercise as adjunctive therapy in psychiatric care: a retrospective cohort study of a new method
Font size:
View:
This is a concise overview. Switch to Full evaluation (Detailed) above for the complete report.
Key Points
1Retrospective cohort evaluation of 'Braining' — a structured group exercise programme — in 239 inpatients and outpatients with predominantly affective and anxiety disorders at a Swedish psychiatric clinic; absence of a comparison group and standardised symptom outcomes limits causal inference.
Major Issues
Methods / Design: No control or comparison group: participants who did not attend Braining (or attended <3 sessions) are not compared, making it impossible to distinguish programme effects from natural illness trajectory, regression to the mean, or non-specific treatment engagement effects.
Methods: No validated psychiatric symptom scale (PHQ-9, GAD-7, HDRS, PANSS) used as a primary outcome; medical record review for subjective improvement is highly susceptible to documentation bias and clinician variability in charting language.
Methods: The ≥3-session adherence threshold for inclusion is not clinically or statistically justified; sensitivity analyses with ≥5 and ≥8 sessions are not reported, making the dose–response relationship unclear.
Results: Attrition and session completion distributions are incompletely reported; median sessions attended and IQR are not provided, preventing calculation of effective dose received by the average participant.
Priority Action Plan
HIGH IMPACT
Problem
Add pre–post validated symptom data (PHQ-9 or GAD-7) from clinical records as the primary outcome; report within-person change with 95% CI and effect size.
Why it matters
Without a validated standardised outcome measure, the study cannot make clinical claims about programme benefit; this is the most critical gap for reviewers at any psychiatric journal.
Suggested fix
Add pre–post validated symptom data (PHQ-9 or GAD-7) from clinical records as the primary outcome; report within-person change with 95% CI and effect size.
HIGH IMPACT
Problem
Implement a comparison group (non-attending eligible patients) with propensity matching on diagnosis, severity, and care setting; or clearly reframe the manuscript as a feasibility/programme description study.
Why it matters
Single-arm designs cannot support effectiveness conclusions; the framing must match the analytic capability to avoid misleading readers.
Suggested fix
Implement a comparison group (non-attending eligible patients) with propensity matching on diagnosis, severity, and care setting; or clearly reframe the manuscript as a feasibility/programme description study.
MEDIUM IMPACT
Problem
Report session attendance as median (IQR) and provide a Kaplan–Meier dropout curve; add a dose–response sensitivity analysis.
Why it matters
Adherence characterisation is central to exercise intervention implementation science and is expected by psychiatric rehabilitation reviewers.
Suggested fix
Report session attendance as median (IQR) and provide a Kaplan–Meier dropout curve; add a dose–response sensitivity analysis.
Quick win: The Braining programme is a well-structured and replicable intervention filling a genuine gap in psychiatric care. Reframing the manuscript explicitly as a feasibility/programme evaluation — or adding PHQ-9/GAD-7 pre–post data — would substantially improve its scientific contribution. The current framing overstates what can be concluded from a retrospective single-arm cohort.